RxDoctor Payments Data

Michael Moeller, MD

Psychiatry · Mankato, MNNPI 1598765877

Payments from drug & device makers

$483in general payments, 2019–2025

Across 29 payments — averaging $16.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$122
  • Otsuka America Pharmaceutical, Inc.$69
  • E.r. Squibb & Sons, L.L.C.$64
  • Lundbeck LLC$63
  • Vanda Pharmaceuticals Inc.$43
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$30
  • plus $92 from 6 others

What the payments were for

  • Food & beverage$483100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$483 in reported general payments places this provider in the 85th percentile of 552 psychiatry providers in Minnesota.

See all psychiatry providers in Minnesota

Medicare billing

Part B allowed, 2024
$14,318
Medicare patients
54
Services billed
124

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate25$74,517
RexultiBrexpiprazole23$33,062
VraylarCariprazine Hcl14$19,916
VyvanseLisdexamfetamine Dimesylate39$16,147
Lurasidone Hcl21$15,049
Olanzapine319$14,086
Quetiapine Fumarate255$8,007
Divalproex Sodium ErDivalproex Sodium110$7,420
Duloxetine Hcl184$3,599
Lisdexamfetamine Dimesylate15$3,391
Bupropion XlBupropion Hcl176$2,919
Clozapine24$2,450
Thioridazine Hcl25$1,802
Venlafaxine Hcl ErVenlafaxine Hcl130$1,643
Atomoxetine Hcl12$1,588

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$15$74,51725 claims
Otsuka America Pharmaceutical, Inc.Rexulti$69$33,06223 claims
AbbVieVraylar$15$19,91614 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$11$16,14739 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 552 psychiatry providers in Minnesota.

Other psychiatry in Mankato

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →